rs587784401

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_001379110.1(SLC9A6):​c.256A>G​(p.Ser86Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000414 in 1,207,043 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000037 ( 0 hom. 2 hem. )

Consequence

SLC9A6
NM_001379110.1 missense

Scores

4
13

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 5.89
Variant links:
Genes affected
SLC9A6 (HGNC:11079): (solute carrier family 9 member A6) This gene encodes a sodium-hydrogen exchanger that is amember of the solute carrier family 9. The encoded protein localizes to early and recycling endosomes and may be involved in regulating endosomal pH and volume. Defects in this gene are associated with X-linked syndromic cognitive disability, Christianson type. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21406034).
BS1
Variant frequency is greater than expected in population eas. gnomad4_exome allele frequency = 0.00000365 (4/1095077) while in subpopulation EAS AF= 0.0000994 (3/30193). AF 95% confidence interval is 0.0000263. There are 0 homozygotes in gnomad4_exome. There are 2 alleles in male gnomad4_exome subpopulation. Median coverage is 29. This position pass quality control queck. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC9A6NM_001379110.1 linkc.256A>G p.Ser86Gly missense_variant Exon 3 of 18 ENST00000630721.3 NP_001366039.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC9A6ENST00000630721.3 linkc.256A>G p.Ser86Gly missense_variant Exon 3 of 18 4 NM_001379110.1 ENSP00000487486.2 A0A0D9SGH0
SLC9A6ENST00000370695.8 linkc.412A>G p.Ser138Gly missense_variant Exon 2 of 16 1 ENSP00000359729.4 Q92581-2
SLC9A6ENST00000370698.7 linkc.412A>G p.Ser138Gly missense_variant Exon 2 of 16 1 ENSP00000359732.3 Q92581-1
SLC9A6ENST00000370701.6 linkc.256A>G p.Ser86Gly missense_variant Exon 3 of 17 1 ENSP00000359735.1 Q92581-3

Frequencies

GnomAD3 genomes
AF:
0.00000894
AC:
1
AN:
111913
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34089
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000279
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000545
AC:
1
AN:
183493
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
67927
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000721
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000365
AC:
4
AN:
1095077
Hom.:
0
Cov.:
29
AF XY:
0.00000555
AC XY:
2
AN XY:
360459
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000994
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000217
GnomAD4 genome
AF:
0.00000893
AC:
1
AN:
111966
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34152
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000279
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Christianson syndrome Uncertain:2
Jun 10, 2014
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 138 of the SLC9A6 protein (p.Ser138Gly). This variant is present in population databases (rs587784401, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with SLC9A6-related conditions. ClinVar contains an entry for this variant (Variation ID: 159935). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC9A6 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not specified Uncertain:1
Aug 08, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: SLC9A6 c.412A>G (p.Ser138Gly) results in a non-conservative amino acid change located in the Cation/H+ exchanger domain (IPR006153) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 5.4e-06 in 183493 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.412A>G in individuals affected with Christianson Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 159935). Based on the evidence outlined above, the variant was classified as uncertain significance. -

not provided Uncertain:1
May 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

SLC9A6: PM2, BP5 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.13
.;.;.;.;.;.;.;T;T;.
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.88
.;.;D;.;.;D;D;D;D;D
M_CAP
Benign
0.045
D
MetaRNN
Benign
0.21
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.64
.;.;.;.;.;.;N;N;.;.
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.7
.;.;.;.;.;N;N;N;.;.
REVEL
Benign
0.24
Sift
Benign
0.25
.;.;.;.;.;T;T;T;.;.
Sift4G
Benign
0.31
.;.;.;.;.;T;T;T;T;.
Polyphen
0.0020
.;.;.;.;.;.;B;B;.;.
Vest4
0.35, 0.36
MutPred
0.57
.;.;.;.;.;.;Loss of glycosylation at S138 (P = 0.029);Loss of glycosylation at S138 (P = 0.029);.;.;
MVP
0.68
MPC
1.7
ClinPred
0.50
T
GERP RS
5.1
Varity_R
0.53
gMVP
0.84

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs587784401; hg19: chrX-135077031; API